MALLINCKRODT
Their evolution as a company starts now, and they are poised for an exciting future. Their core strengths provide the impetus for future success, including skills in the acquisition and management of highly regulated raw materials; strong regulatory knowledge, reputation, and relationships; distinctive manufacturing and logistics skills where vertical integration is an advantage; expertise in specialized chemistry, development, and formulation; and global commercial reach.
MALLINCKRODT
Social Links:
Industry:
Biotechnology
Founded:
1867-01-01
Address:
Blanchardstown, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.mallinckrodt.com
Total Employee:
5001+
Status:
Active
Contact:
+1 314-654-2000
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2017-12-26 | Sucampo Pharmaceuticals | Sucampo Pharmaceuticals acquired by Mallinckrodt | 1.2 B USD |
2017-11-02 | Ocera Therapeutics | Ocera Therapeutics acquired by Mallinckrodt | 42 M USD |
2017-08-04 | InfaCare Pharmaceutical | InfaCare Pharmaceutical acquired by Mallinckrodt | N/A |
2016-08-10 | Stratatech Corporation | Stratatech Corporation acquired by Mallinckrodt | N/A |
2015-08-10 | Therakos | Therakos acquired by Mallinckrodt | 1.33 B USD |
2015-03-05 | Ikaria | Ikaria acquired by Mallinckrodt | 2.3 B USD |
2014-04-07 | Questcor Pharmaceuticals | Questcor Pharmaceuticals acquired by Mallinckrodt | N/A |
2014-02-11 | Cadence Pharmaceuticals | Cadence Pharmaceuticals acquired by Mallinckrodt | N/A |
2012-09-24 | CNS Therapeutics (Old) | CNS Therapeutics (Old) acquired by Mallinckrodt | 100 M USD |
1997-07-24 | Nellcor Puritan Bennett | Nellcor Puritan Bennett acquired by Mallinckrodt | 1.81 B USD |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2019-07-18 | Silence Therapeutics | Mallinckrodt investment in Post-IPO Equity - Silence Therapeutics | 5 M USD |
Newest Events participated
Official Site Inspections
http://www.mallinckrodt.com Semrush global rank: 1.88 M Semrush visits lastest month: 11.69 K
- Host name: 45.60.250.79
- IP address: 45.60.250.79
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago